Xtl Biopharmaceuticals (XTLB) Enterprise Value (2011 - 2025)
Xtl Biopharmaceuticals' Enterprise Value was $2.2 billion in the quarter ended Dec 31, 2025, up 60.8% from $1.37 billion a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Enterprise Value (2011 - 2025) Analysis & Trends
From the quarter ended Dec 31, 2011 onward, Xtl Biopharmaceuticals has reported Enterprise Value for 55 quarters.
- Enterprise Value shows a five-year compound annual growth rate of 7.2% (years ended Dec 2020 to Dec 2025).
- In earlier years, Enterprise Value was $1.37 billion in the year ended Dec 31, 2024 (+149.3%), $547.66 million in the year ended Dec 31, 2023 (-16.4%), $654.74 million in the year ended Dec 31, 2022 (-56.4%) and $1.5 billion in the year ended Dec 31, 2021 (-3.1%).
- The figure for the quarter ended Dec 31, 2025 marks the highest quarterly Enterprise Value since the quarter ended Sep 30, 2021.
- Compared with a year earlier, Enterprise Value was higher in five of the last six quarters, with growth averaging 99.0%.
- The best year-over-year quarter for Enterprise Value over five years was the quarter ended Mar 31, 2021 (growth of 183.6%); the worst was the quarter ended Sep 30, 2022 (a decline of 73.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Xtl Biopharmaceuticals | 18.55 Mn | 15.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 21.88 Mn |
| Jun 30, 2025 | 9.79 Mn |
| Dec 31, 2024 | 16.75 Mn |
| Sep 30, 2024 | 11.36 Mn |
| Jun 30, 2024 | 11.66 Mn |
| Mar 31, 2024 | 12.97 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Sep 30, 2023 | 2.70 Mn |
| Jun 30, 2023 | 3.07 Mn |
| Mar 31, 2023 | 4.26 Mn |
| Dec 31, 2022 | 2.87 Mn |
| Sep 30, 2022 | 1.66 Mn |
| Jun 30, 2022 | 3.13 Mn |
| Mar 31, 2022 | 10.12 Mn |
| Dec 31, 2021 | 8.97 Mn |
| Sep 30, 2021 | 19.51 Mn |
| Jun 30, 2021 | 14.22 Mn |
| Mar 31, 2021 | 13.73 Mn |
| Dec 31, 2020 | 9.54 Mn |
| Sep 30, 2020 | 6.02 Mn |
API Access
Xtl Biopharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();